Aridis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-…

Biotechnology
US, Los Gatos [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ARDS's Analysis
CIK: 1614067 CUSIP: 040334104 ISIN: US0403341045 LEI: - UEI: -
Secondary Listings
ARDS has no secondary listings inside our databases.